These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
742 related articles for article (PubMed ID: 26715839)
1. Autophagy facilitates lung adenocarcinoma resistance to cisplatin treatment by activation of AMPK/mTOR signaling pathway. Wu T; Wang MC; Jing L; Liu ZY; Guo H; Liu Y; Bai YY; Cheng YZ; Nan KJ; Liang X Drug Des Devel Ther; 2015; 9():6421-31. PubMed ID: 26715839 [TBL] [Abstract][Full Text] [Related]
2. Neferine augments therapeutic efficacy of cisplatin through ROS- mediated non-canonical autophagy in human lung adenocarcinoma (A549 cells). Kalai Selvi S; Vinoth A; Varadharajan T; Weng CF; Vijaya Padma V Food Chem Toxicol; 2017 May; 103():28-40. PubMed ID: 28223119 [TBL] [Abstract][Full Text] [Related]
3. Ginsenoside metabolite compound K induces apoptosis and autophagy in non-small cell lung cancer cells via AMPK-mTOR and JNK pathways. Li C; Dong Y; Wang L; Xu G; Yang Q; Tang X; Qiao Y; Cong Z Biochem Cell Biol; 2019 Aug; 97(4):406-414. PubMed ID: 30475650 [TBL] [Abstract][Full Text] [Related]
4. Mimulone-induced autophagy through p53-mediated AMPK/mTOR pathway increases caspase-mediated apoptotic cell death in A549 human lung cancer cells. An HK; Kim KS; Lee JW; Park MH; Moon HI; Park SJ; Baik JS; Kim CH; Lee YC PLoS One; 2014; 9(12):e114607. PubMed ID: 25490748 [TBL] [Abstract][Full Text] [Related]
5. Resveratrol-induced autophagy and apoptosis in cisplatin-resistant human oral cancer CAR cells: A key role of AMPK and Akt/mTOR signaling. Chang CH; Lee CY; Lu CC; Tsai FJ; Hsu YM; Tsao JW; Juan YN; Chiu HY; Yang JS; Wang CC Int J Oncol; 2017 Mar; 50(3):873-882. PubMed ID: 28197628 [TBL] [Abstract][Full Text] [Related]
6. XPC inhibition rescues cisplatin resistance via the Akt/mTOR signaling pathway in A549/DDP lung adenocarcinoma cells. Teng X; Fan XF; Li Q; Liu S; Wu DY; Wang SY; Shi Y; Dong M Oncol Rep; 2019 Mar; 41(3):1875-1882. PubMed ID: 30628719 [TBL] [Abstract][Full Text] [Related]
7. 4-Acetylantroquinonol B suppresses autophagic flux and improves cisplatin sensitivity in highly aggressive epithelial cancer through the PI3K/Akt/mTOR/p70S6K signaling pathway. Liu M; Bamodu OA; Huang WC; Zucha MA; Lin YK; Wu ATH; Huang CC; Lee WH; Yuan CC; Hsiao M; Deng L; Tzeng YM; Yeh CT Toxicol Appl Pharmacol; 2017 Jun; 325():48-60. PubMed ID: 28408137 [TBL] [Abstract][Full Text] [Related]
8. Effects of VBMDMP on the reversal of cisplatin resistance in human lung cancer A549/DDP cells. Wang CK; Zhang Y; Zhang ZJ; Qiu QW; Cao JG; He ZM Oncol Rep; 2015 Jan; 33(1):372-82. PubMed ID: 25394854 [TBL] [Abstract][Full Text] [Related]
9. Bisdemethoxycurcumin sensitizes cisplatin-resistant lung cancer cells to chemotherapy by inhibition of CA916798 and PI3K/AKT signaling. Wang HJ; Yang ZX; Dai XT; Chen YF; Yang HP; Zhou XD Apoptosis; 2017 Sep; 22(9):1157-1168. PubMed ID: 28677094 [TBL] [Abstract][Full Text] [Related]
10. Metformin enhances cisplatin cytotoxicity by suppressing signal transducer and activator of transcription-3 activity independently of the liver kinase B1-AMP-activated protein kinase pathway. Lin CC; Yeh HH; Huang WL; Yan JJ; Lai WW; Su WP; Chen HH; Su WC Am J Respir Cell Mol Biol; 2013 Aug; 49(2):241-50. PubMed ID: 23526220 [TBL] [Abstract][Full Text] [Related]
11. Cabazitaxel-induced autophagy via the PI3K/Akt/mTOR pathway contributes to A549 cell death. Huo R; Wang L; Liu P; Zhao Y; Zhang C; Bai B; Liu X; Shi C; Wei S; Zhang H Mol Med Rep; 2016 Oct; 14(4):3013-20. PubMed ID: 27572899 [TBL] [Abstract][Full Text] [Related]
12. Co-treatment with BEZ235 enhances chemosensitivity of A549/DDP cells to cisplatin via inhibition of PI3K/Akt/mTOR signaling and downregulation of ERCC1 expression. Xia A; Li H; Li R; Lu L; Wu X Oncol Rep; 2018 Oct; 40(4):2353-2362. PubMed ID: 30066933 [TBL] [Abstract][Full Text] [Related]
13. Salvianolic acid A reverses cisplatin resistance in lung cancer A549 cells by targeting c-met and attenuating Akt/mTOR pathway. Tang XL; Yan L; Zhu L; Jiao DM; Chen J; Chen QY J Pharmacol Sci; 2017 Sep; 135(1):1-7. PubMed ID: 28939129 [TBL] [Abstract][Full Text] [Related]
14. Ginkgo biloba exocarp extracts induces autophagy in Lewis lung cancer cells involving AMPK / mTOR / p70S6k signaling pathway. Cao C; Han D; Su Y; Ge Y; Chen H; Xu A Biomed Pharmacother; 2017 Sep; 93():1128-1135. PubMed ID: 28738521 [TBL] [Abstract][Full Text] [Related]
15. A hybrid of coumarin and phenylsulfonylfuroxan induces caspase-dependent apoptosis and cytoprotective autophagy in lung adenocarcinoma cells. Wang Q; Guo Y; Jiang S; Dong M; Kuerban K; Li J; Feng M; Chen Y; Ye L Phytomedicine; 2018 Jan; 39():160-167. PubMed ID: 29433677 [TBL] [Abstract][Full Text] [Related]
16. miR-21 modulates cisplatin resistance of gastric cancer cells by inhibiting autophagy via the PI3K/Akt/mTOR pathway. Gu Y; Fei Z; Zhu R Anticancer Drugs; 2020 Apr; 31(4):385-393. PubMed ID: 31913198 [TBL] [Abstract][Full Text] [Related]
17. TAZ inhibition restores sensitivity of cisplatin via AKT/mTOR signaling in lung adenocarcinoma. Xu W; Wei Y; Li Y; Yin Y; Yuan W; Yang Y; Zhao W; Wu J Oncol Rep; 2017 Sep; 38(3):1815-1821. PubMed ID: 28737828 [TBL] [Abstract][Full Text] [Related]
18. CNTN-1 Enhances Chemoresistance in Human Lung Adenocarcinoma Through Induction of Epithelial-Mesenchymal Transition by Targeting the PI3K/Akt Pathway. Zhang R; Sun S; Ji F; Liu C; Lin H; Xie L; Yang H; Tang W; Zhou Y; Xu J; Li P Cell Physiol Biochem; 2017; 43(2):465-480. PubMed ID: 28934754 [TBL] [Abstract][Full Text] [Related]
19. Licoricidin inhibits the growth of SW480 human colorectal adenocarcinoma cells in vitro and in vivo by inducing cycle arrest, apoptosis and autophagy. Ji S; Tang S; Li K; Li Z; Liang W; Qiao X; Wang Q; Yu S; Ye M Toxicol Appl Pharmacol; 2017 Jul; 326():25-33. PubMed ID: 28416456 [TBL] [Abstract][Full Text] [Related]
20. Chloroquine enhances the efficacy of cisplatin by suppressing autophagy in human adrenocortical carcinoma treatment. Qin L; Xu T; Xia L; Wang X; Zhang X; Zhang X; Zhu Z; Zhong S; Wang C; Shen Z Drug Des Devel Ther; 2016; 10():1035-45. PubMed ID: 27022243 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]